OrbusNeich Medical Group Holdings Future Growth
Future criteria checks 1/6
OrbusNeich Medical Group Holdings's earnings are forecast to decline at 3.1% per annum while its annual revenue is expected to grow at 11.3% per year. EPS is expected to decline by 1.9% per annum. Return on equity is forecast to be 8.1% in 3 years.
Key information
-3.1%
Earnings growth rate
-1.9%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 11.3% |
| Future return on equity | 8.1% |
| Analyst coverage | Low |
| Last updated | 24 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 207 | 43 | 50 | 53 | 2 |
| 12/31/2025 | 194 | 42 | 34 | 45 | 3 |
| 12/31/2024 | 169 | 37 | 32 | 45 | 3 |
| 6/30/2024 | 151 | 39 | 8 | 19 | N/A |
| 3/31/2024 | 153 | 42 | 12 | 21 | N/A |
| 12/31/2023 | 154 | 45 | 17 | 23 | N/A |
| 9/30/2023 | 152 | 40 | 17 | 22 | N/A |
| 6/30/2023 | 149 | 36 | 18 | 22 | N/A |
| 3/31/2023 | 143 | 27 | 19 | 23 | N/A |
| 12/31/2022 | 137 | 18 | 20 | 23 | N/A |
| 9/30/2022 | 132 | 9 | 19 | 22 | N/A |
| 6/30/2022 | 128 | 0 | 18 | 20 | N/A |
| 3/31/2022 | 122 | -2 | 18 | 20 | N/A |
| 12/31/2021 | 116 | -4 | 18 | 20 | N/A |
| 12/31/2020 | 88 | 7 | 9 | 13 | N/A |
| 12/31/2019 | 96 | 7 | -1 | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Q8T's earnings are forecast to decline over the next 3 years (-3.1% per year).
Earnings vs Market: Q8T's earnings are forecast to decline over the next 3 years (-3.1% per year).
High Growth Earnings: Q8T's earnings are forecast to decline over the next 3 years.
Revenue vs Market: Q8T's revenue (11.3% per year) is forecast to grow faster than the German market (5.7% per year).
High Growth Revenue: Q8T's revenue (11.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Q8T's Return on Equity is forecast to be low in 3 years time (8.1%).